Abzena’s interim results highlight continued investment across its increasingly integrated Services offering. Performance for the full year is expected to be H2 weighted, with a stronger H2 propelled in particular by recent chemistry research services contract wins and a revitalised biology research services offering. The installation of bioreactors in San Diego is on track, with the first (500l), bioreactor due for installation this month and a second (2,000l) to follow in Q1. Meanwhile, the le ....
12 Dec 2017
N+1 Singer - Abzena - Recent contract wins support H2 weighting
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Abzena - Recent contract wins support H2 weighting
Abzena (ABZA:LON) | 0 0 (-0.9%) | Mkt Cap: 54.0m
- Published:
12 Dec 2017 -
Author:
Dr Jens Lindqvist -
Pages:
3
Abzena’s interim results highlight continued investment across its increasingly integrated Services offering. Performance for the full year is expected to be H2 weighted, with a stronger H2 propelled in particular by recent chemistry research services contract wins and a revitalised biology research services offering. The installation of bioreactors in San Diego is on track, with the first (500l), bioreactor due for installation this month and a second (2,000l) to follow in Q1. Meanwhile, the le ....